Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasiliki Kalatzis

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2002
Cystinosis: from gene to diseaseVasiliki Kalatzis, Corinne Antignac
Pediatric Nephrology (Berlin, Germany)|March 20, 2003
New aspects of the pathogenesis of cystinosisVasiliki Kalatzis, Corinne Antignac
Neural Plasticity|June 2, 2018
Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell TherapyCarla Sanjurjo-Soriano, Vasiliki Kalatzis
Molecular Diagnosis & Therapy|October 18, 2021
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to DateVasiliki Kalatzis, Anne-Françoise Roux, Isabelle Meunier
American Journal of Ophthalmology|July 2, 2013
Choroideremia: towards a therapyVasiliki Kalatzis, Christian P Hamel, Ian M MacDonald, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 23, 2021
CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC LinesCarla Sanjurjo-Soriano, Nejla Erkilic, Daria Mamaeva, et al.
Human Molecular Genetics|May 7, 2004
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosinVasiliki Kalatzis, Nathalie Nevo, Stéphanie Cherqui, et al.
International Journal of Molecular Sciences|May 26, 2019
Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis PigmentosaMichalitsa Diakatou, Gaël Manes, Beatrice Bocquet, et al.
Stem Cell Research|June 27, 2026
Generation of an induced pluripotent stem cell line, LGMi002-A, from a Bardet-Biedl Syndrome patient with a BBS5 homozygous pathogenic variantSamira Secula, Nejla Erkilic, Cathy Obringer, et al.
International Journal of Molecular Sciences|April 3, 2021
Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3Michalitsa Diakatou, Gregor Dubois, Nejla Erkilic, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2002
Cystinosis: from gene to diseaseVasiliki Kalatzis, Corinne Antignac
Pediatric Nephrology (Berlin, Germany)|March 20, 2003
New aspects of the pathogenesis of cystinosisVasiliki Kalatzis, Corinne Antignac
Neural Plasticity|June 2, 2018
Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell TherapyCarla Sanjurjo-Soriano, Vasiliki Kalatzis
Molecular Diagnosis & Therapy|October 18, 2021
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to DateVasiliki Kalatzis, Anne-Françoise Roux, Isabelle Meunier
American Journal of Ophthalmology|July 2, 2013
Choroideremia: towards a therapyVasiliki Kalatzis, Christian P Hamel, Ian M MacDonald, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 23, 2021
CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC LinesCarla Sanjurjo-Soriano, Nejla Erkilic, Daria Mamaeva, et al.
Human Molecular Genetics|May 7, 2004
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosinVasiliki Kalatzis, Nathalie Nevo, Stéphanie Cherqui, et al.
International Journal of Molecular Sciences|May 26, 2019
Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis PigmentosaMichalitsa Diakatou, Gaël Manes, Beatrice Bocquet, et al.
Stem Cell Research|June 27, 2026
Generation of an induced pluripotent stem cell line, LGMi002-A, from a Bardet-Biedl Syndrome patient with a BBS5 homozygous pathogenic variantSamira Secula, Nejla Erkilic, Cathy Obringer, et al.
International Journal of Molecular Sciences|April 3, 2021
Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3Michalitsa Diakatou, Gregor Dubois, Nejla Erkilic, et al.
Pageof 8